NTLA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Intellia Therapeutics (NTLA) Earnings Date & Reports

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NTLA is expected to report earnings to -126 cents per share on May 01

Intellia Therapeutics NTLA Stock Earnings Reports

Q1'25

Est.

$-1.27

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.30

Q1'24

Beat

by $0.26

The last earnings report on February 27 showed earnings per share of -126 cents, beating the estimate of -134 cents. With 2.46M shares outstanding, the current market capitalization sits at 688.91M.

View a ticker or compare two or three

Compare

NTLA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NTLA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NTLA (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Erie Street

Phone

+1 857 285-6200

Employees

526

Web

https://www.intelliatx.com